Merryclin Pharmaceuticals Co., Ltd., established in the Yunmeng Economic Development Zone, in Hubei Province in 2011, is a rising hi-tech enterprise, which specializes in R&D, Production and business of API and Medical Intermediates.

Our plants, with 12 production lines, are built according to the international GMP standards. Moreover, we have obtained the EU certifications, and expanded our brand advantages into the international market. Our company has its own research institute, which makes cooperation with South-Central University in Hunan for nationalities to establish joint R&D centre, thus we can commit to the development of the development of the ethnomedicine and the research on the industrialization. In addition we have set a joint laboratory based on the cooperation with Xiangya School of medicine of Central South University in Hunan, which aims at the development of new chemicals.

At present, the institute has invested over 40 million Yuan in product development, which laid a solid foundation for the smooth operation of the Merryclin Pharmaceuticals. We have a whole set of advanced develop, research and production equipments with minimum annual output of 1,000 metric tons. All of our products, individual elements, active ingredients and medical intermediates, strictly complies with the GMP in production process. To guarantee the quality, a mature and advanced quality control system has been established, which bases on a high-level quality analysis center with our professional technical personnel and outstanding management team.

Improving our products & services to make customers enjoy more infectious, natural and safer products is our great mission. Meanwhile, we always keep a close watch on the various demands for the API in the international market, and have increased some more new product items.